CNTB SCHEDULE 13G/A: SEC filing
Ikarian Capital, LLC and Neil Shahrestani
Filed with the SEC on · accession 0001778253-26-000007
CNTB filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -5.1% by the first close after the filing.
Summary of the filing
Ikarian Capital, LLC and Neil Shahrestani filed an amended Schedule 13G reporting beneficial ownership of 2,163,352 ordinary shares, or 3.4%, of Connect Biopharma Holdings Ltd as of September 30, 2026.
Key details
How CNTB stock reacted
Close before
$0.68
Nov 13, 2026
First close after
-5.05%
$0.64
5 trading days
—
Since filing
-14.53%
$0.58
✦ Ask GOAX AI about this filing — what it means for CNTB, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CNTB?
Click hereFrequently asked questions
What did CNTB file with the SEC on Nov 16, 2026?
CNTB filed a SCHEDULE 13G/A (SEC filing). Ikarian Capital, LLC and Neil Shahrestani filed an amended Schedule 13G reporting beneficial ownership of 2,163,352 ordinary shares, or 3.4%, of Connect Biopharma Holdings Ltd as of September 30, 2026.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did CNTB stock react to this filing?
CNTB closed at $0.68 before the filing and $0.64 on Nov 16, 2026 (-5.05%).
Other CNTB SEC filings
- 10-Q · SEC filingNov 16, 2026
- 8-K · Delisting noticeNov 16, 2026
- SCHEDULE 13G/A · SEC filingNov 3, 2026
- SCHEDULE 13G · SEC filingOct 6, 2026
- 8-K · Fda approvalSep 30, 2026
- 8-K · Fda approvalSep 15, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 10-Q · SEC filingAug 12, 2026
- 8-K · SEC filingAug 12, 2026
Get alerts when CNTB files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days